$159.60
-0.02[-0.01%]
Last update: 9:29AM Get Real Time Here
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/26/2024 | ABBV | AbbVie | FY | 2024 | $11.13 | $11.33 | $11.10 | $55.00B | $55.00B | $54.60B | Get Alert |
04/26/2024 | ABBV | AbbVie | Q2 | 2024 | $3.05 | $3.09 | $2.81 | $14.00B | $14.00B | $13.57B | Get Alert |
04/03/2024 | ABBV | AbbVie | Q1 | 2024 | $2.18 | $2.22 | $2.33 | — | — | — | Get Alert |
04/03/2024 | ABBV | AbbVie | FY | 2024 | $10.97 | $11.17 | $11.19 | — | — | — | Get Alert |
02/12/2024 | ABBV | AbbVie | FY | 2024 | $11.05 | $11.25 | $11.18 | — | — | — | Get Alert |
02/12/2024 | ABBV | AbbVie | Q1 | 2024 | $2.26 | $2.30 | $2.39 | — | — | — | Get Alert |
02/02/2024 | ABBV | AbbVie | Q1 | 2024 | $2.30 | $2.34 | $2.31 | $11.90B | $11.90B | $11.37B | Get Alert |
02/02/2024 | ABBV | AbbVie | FY | 2024 | $11.05 | $11.25 | $11.24 | $54.20B | $54.20B | $49.94B | Get Alert |
01/05/2024 | ABBV | AbbVie | FY | 2023 | $11.04 | $11.08 | $11.22 | — | — | — | Get Alert |
01/05/2024 | ABBV | AbbVie | Q4 | 2023 | $2.72 | $2.76 | $2.90 | — | — | — | Get Alert |
10/27/2023 | ABBV | AbbVie | FY | 2023 | $11.19 | $11.23 | $10.42 | — | — | — | Get Alert |
10/27/2023 | ABBV | AbbVie | FY | 2024 | $11.00 | $11.00 | $10.45 | — | — | — | Get Alert |
10/04/2023 | ABBV | AbbVie | FY | 2023 | $10.86 | $11.06 | $11.07 | — | — | — | Get Alert |
10/04/2023 | ABBV | AbbVie | Q3 | 2023 | $2.76 | $2.86 | $2.88 | — | — | — | Get Alert |
07/27/2023 | ABBV | AbbVie | Q3 | 2023 | $2.80 | $2.90 | $2.82 | $13.70B | $13.70B | $13.35B | Get Alert |
07/27/2023 | ABBV | AbbVie | FY | 2023 | $10.90 | $11.10 | $10.87 | — | — | — | Get Alert |
07/06/2023 | ABBV | AbbVie | FY | 2023 | $10.57 | $10.97 | $10.08 | — | — | — | Get Alert |
07/06/2023 | ABBV | AbbVie | Q2 | 2023 | $2.75 | $2.85 | $2.69 | — | — | — | Get Alert |
04/27/2023 | ABBV | AbbVie | Q2 | 2023 | $2.90 | $3.00 | $2.85 | $13.50B | $13.50B | $13.36B | Get Alert |
The last reported Earnings numbers were from April 26, 2024 for the full year 2024 and was for an earnings per share guidance in the range of $11.13 and $11.33 versus the estimated EPS of $11.10.
Browse guidance and forecast on all stocks.